Table 3: Association between origin or etiology of sepsis, empiric therapy and 30-day mortality.
Outcome | 30-day mortality | ||
Antibiotic | CRB | Non-CRB | |
Origin of sepsis | UTI | 11/34 (32.4%) | 76/219 (34.7%) |
RTI | 17/82 (20.7%) | 24/113 (21.2%) | |
Other | 3/11 (27.3%) | 15/38 (39.5%) | |
Unknown | 1/18 (5.6%) | 7/32 (21.9%) | |
Aetiology of sepsis | Identified, ESBL-E | 10/58 (17.2%) | 28/97 (28.9%) |
Identified, not ESBL-E | 12/51 (23.5%) | 44/134 (32.8%) | |
Unidentified | 10/36 (27.8%) | 50/171 (29.2%) |
Data are number (%).
CRB: carbapenem; ESBL-E: extended-spectrum β-lactamase-producing Enterobacteriaceae; RTI: respiratory tract infection; UTI: urinary tract infection.